JCM | Free Full-Text | An Application of Machine Learning That Uses the Magnetic Resonance Imaging Metric, Mean Apparent Diffusion Coefficient, to Differentiate between the Histological Types of Ovarian Cancer | HTML
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
/cancer-antigen-15-3-blood-test-for-breast-cancer-430608-Final-3ff12d280e8f4828beab8217d557c685.jpg "Cancer Antigen 15-3 Test: Uses, Procedure, Results")
Cancer Antigen 15-3 Test: Uses, Procedure, Results
Appendiceal mucinous neoplasm mimics ovarian tumors: Challenges for preoperative and intraoperative diagnosis and clinical implication - European Journal of Surgical Oncology
Cancers | Free Full-Text | The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic | HTML
PDF) Mahendar Porika, Nagulu Malotu, Uday Kiran Veldandi, Nalini Yadala, Sadanandam Abbagani (2010). Evaluation of Tumor Markers in Southern Indian Breast Cancer Patients. Asian Pac J Cancer Prev. 11 (1):157-159.
Frontiers | Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer | Oncology
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
PDF) Mahendar Porika, Nagulu Malotu, Uday Kiran Veldandi, Nalini Yadala, Sadanandam Abbagani (2010). Evaluation of Tumor Markers in Southern Indian Breast Cancer Patients. Asian Pac J Cancer Prev. 11 (1):157-159.
Next-generation regulatory T cell therapy | Nature Reviews Drug Discovery
Evaluation of Tumor Markers in Southern Indian Breast Cancer ...
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
Assessing Clinical Significance of Serum CA15-3 and Carcinoembryonic Antigen (CEA) Levels in Breast Cancer Patients: A Meta-Analysis | Semantic Scholar
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer | British Journal of Cancer
CA153 and CEA as Candidate Tumor Markers in Diagnosing the Cause of MPE | Download Table
An individual reference limit of the serum CEA-TPA-CA 15-3 tumor marke | CMAR
CA153 and CEA as Candidate Tumor Markers in Diagnosing the Cause of MPE | Download Table
Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients. | Semantic Scholar
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection | bioRxiv
An individual reference limit of the serum CEA-TPA-CA 15-3 tumor marke | CMAR
CA153 and CEA as Candidate Tumor Markers in Diagnosing the Cause of MPE | Download Table
Assessing Clinical Significance of Serum CA15-3 and Carcinoembryonic Antigen (CEA) Levels in Breast Cancer Patients: A Meta-Analysis | Semantic Scholar
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma
CA153 and CEA as Candidate Tumor Markers in Diagnosing the Cause of MPE | Download Table
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection - ScienceDirect
